Amanote Research
Register
Sign In
Dopamine/Serotonin Receptor Ligands. 131: Homologization of a Benzindoloazecine-Type Dopamine Receptor Antagonist Modulates the Affinities for Dopamine D1-D5 Receptors
doi 10.1021/jm060213k.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Correction To: Dopamine D1 Receptor Antagonist Reduces Stimulant-Induced Conditioned Place Preferences and Dopamine Receptor Supersensitivity
Naunyn-Schmiedeberg's Archives of Pharmacology
Medicine
Pharmacology
Heteromerization of Dopamine D2 Receptors With Dopamine D1 or D5 Receptors Generates Intracellular Calcium Signaling by Different Mechanisms
Current Opinion in Pharmacology
Drug Discovery
Pharmacology
Modulation of T-Cell Mediated Immunity by Dopamine Receptor D5
Endocrine, Metabolic and Immune Disorders - Drug Targets
Endocrinology
Allergy
Immunology
Metabolism
Diabetes
Striatal Dopamine D1 Receptor Is Essential for Contextual Fear Conditioning
Scientific Reports
Multidisciplinary
Phosphorylation Barcode-Dependent Signal Bias of the Dopamine D1 Receptor
Striatal Serotonin Receptors and Dopamine Release
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular
Association of Dopamine-Related Genetic Loci to Dopamine D3 Receptor Antagonist ABT-925 Clinical Response
Translational Psychiatry
Psychiatry
Molecular Neuroscience
Biological Psychiatry
Mental Health
Cellular
Dopamine D1 Receptor Gene Variation Modulates Opioid Dependence Risk by Affecting Transition to Addiction
PLoS ONE
Multidisciplinary
D1 and D2 Dopamine Receptor mRNA in Rat Brain.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
